# Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

> **NCT06962813** · NA · COMPLETED · sponsor: **Science Valley Research Institute** · enrollment: 46 (actual)

## Conditions studied

- Varicose Veins Leg
- Telangiectasias

## Interventions

- **PROCEDURE:** Radiofrequency V Eraser

## Key facts

- **NCT ID:** NCT06962813
- **Lead sponsor:** Science Valley Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-10
- **Primary completion:** 2025-01-02
- **Final completion:** 2025-04-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962813, "Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06962813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*